Versigent PLC (VGNT) is a publicly traded the market company. As of November 4, 2026, VGNT trades at $39.57 with a market cap of $2.90B and a P/E ratio of 0.00. VGNT moved -2.76% today. Year to date, VGNT is +0.00%; over the trailing twelve months it is flat. Its 52-week range spans $26.34 to $50.89. Analyst consensus is strong buy with an average price target of $56.88. Rallies surfaces VGNT's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
Versigent Q3 2026 net income falls 6% to $102 million; sales rise 7% to $2.45 billion: Versigent’s third-quarter 2026 net income attributable to shareholders fell 6% year over year to $102 million, while net sales rose 7% to $2.45 billion. The company narrowed full-year sales guidance to $9.5 billion–$9.6 billion, with a higher midpoint.
| Metric | Value |
|---|---|
| Price | $39.57 |
| Market Cap | $2.90B |
| P/E Ratio | 0.00 |
| EPS | $0.00 |
| Dividend Yield | 0.13% |
| 52-Week High | $50.89 |
| 52-Week Low | $26.34 |
| Volume | 373 |
| Avg Volume | 0 |
| Revenue (TTM) | $0 |
| Net Income | $0 |
| Gross Margin | 0.00% |
9 analysts cover VGNT: 0 strong buy, 8 buy, 1 hold, 0 sell, 0 strong sell. Consensus rating is strong buy. Average price target: $56.88.